fluorodeoxyglucose f18 has been researched along with Carcinoma, Ductal, Breast in 133 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (7.52) | 18.2507 |
2000's | 39 (29.32) | 29.6817 |
2010's | 74 (55.64) | 24.3611 |
2020's | 10 (7.52) | 2.80 |
Authors | Studies |
---|---|
Choi, YJ; Kang, T; Kim, H; Kim, IJ; Kim, K; Pak, K; Seol, YM | 1 |
Albatineh, AN; Sarikaya, A; Sarikaya, I; Sezer, YA; Tastekin, E | 1 |
Hong, JH; Kwon, SJ; Lee, A; Lee, J; Lee, SW; Park, HL; Park, SY; Yoo, IR | 1 |
Cao, G; Fan, H; Liu, Y; Shao, W; Shi, X; Wang, W; Zhang, J | 1 |
Hanazaki, K; Kitagawa, H; Kobayashi, M; Maeda, H; Namikawa, T; Satake, H; Seo, S; Sugimoto, T; Tamura, M; Yokota, K | 1 |
Fujii, T; Hirakata, T; Honda, C; Kaira, K; Katayama, A; Kurozumi, S; Nakazawa, Y; Obayashi, S; Oyama, T; Shirabe, K; Tokuda, S; Yajima, R; Yanai, K | 1 |
Bellon, J; Cheng, SC; DiPiro, PJ; Hu, J; Jacene, HA; Nakhlis, F; Overmoyer, B; Rosenbluth, JM; Schlosnagle, E; Warren, L; Yeh, E | 1 |
Ejilemele, AA; Nava, VE | 1 |
Chae, YS; Jeong, SY; Jung, JH; Lee, IH; Lee, J; Lee, SJ; Lee, SW; Park, HY | 1 |
Song, BI | 1 |
Kim, BS; Yoo, J; Yoon, HJ | 1 |
Catalano, M; Catalano, OA; Catana, C; Daye, D; Filomena, M; Fuin, N; Iannace, C; Luongo, A; Mahmood, U; Mansi, L; Rosen, BR; Salvatore, M; Signore, A; Soricelli, A; Vangel, M | 1 |
Elboğa, U; Şahin, E | 1 |
Das, PK; Jena, A; Negi, P; Sarin, R; Singh, A; Singhal, M; Taneja, S | 1 |
Chung, J; Kim, BS; Yoo, J; Yoon, HJ | 1 |
Fujii, T; Hirakata, T; Kurozumi, S; Kuwano, H; Nakazawa, Y; Obayashi, S; Tokuda, S; Yajima, R; Yanai, K | 1 |
Ege Aktas, G; Sarikaya, A; Taştekin, E | 1 |
An, YS; Jung, Y; Kang, DK; Kim, TH | 1 |
Chae, YS; Jeong, SY; Jung, JH; Kim, HJ; Kim, WH; Lee, SW; Lee, WK; Park, HY | 1 |
Fujii, T; Hirakata, T; Kurozumi, S; Nakazawa, Y; Obayashi, S; Shirabe, K; Tokuda, S; Yajima, R; Yanai, K | 1 |
Choi, YY; Chung, MS; Lee, SJ; Shin, SJ | 1 |
Diamond, T; Kumar, S | 1 |
Krombach, GA; Litzlbauer, D; Wörner, JM | 1 |
Albano, D; Durmo, R; Giubbini, R | 1 |
Amersi, F; Chung, A; Giuliano, AE; Lee, M; Luu, M; Srour, MK; Walcott-Sapp, S | 1 |
Chang, CC; Chang, SM; Chen, CJ; Hsu, WL; Huang, YF; Tyan, YC | 1 |
Can, C; Komek, H | 1 |
Chang, CC; Chen, YW; Hou, MF; Huang, CJ; Lin, CY; Yang, WC | 1 |
Dobbs, NB; Latifi, HR | 1 |
Elkhuizen, PH; Koolen, BB; Rutgers, EJ; Valdés Olmos, RA; van der Leij, F; Vogel, WV; Vrancken Peeters, MJ | 1 |
Byun, BH; Cho, AR; Choi, CW; Kim, BI; Kim, EK; Kim, HA; Kim, KM; Lee, SS; Lim, I; Lim, SM; Noh, WC; Park, JA | 1 |
Emi, A; Kadoya, T; Masumoto, N; Ohara, M; Okada, M; Ozaki, S; Shigematsu, H; Tsutani, Y | 1 |
Aliyev, A; Arslan, E; Ekmekcioglu, O; Erkan, ME; Halac, M; Kaya, R; Kocael, P; Sonmezoglu, K; Yilmaz, S | 1 |
Andrade, WP; Baiocchi, G; Bitencourt, AG; Damascena, AS; do Socorro Maciel, M; Fanelli, MF; Lima, EN; Osório, CA; Soares, FA | 1 |
Ahn, SH; Chae, SY; Gong, GY; Kim, HO; Lee, JJ; Lee, JW; Moon, DH; Park, SH; Ryu, JS; Seo, MJ; Son, BH | 1 |
Agresti, R; Alessi, A; Barbara, P; Bianchi, G; Bombardieri, E; Carcangiu, ML; Crippa, F; Ferraris, C; Greco, M; Maccauro, M; Martelli, G; Maugeri, I; Moscaroli, A; Pellitteri, C; Rampa, M; Sandri, M; Tagliabue, E | 1 |
Aide, N; Allouache, D; Bellevre, D; Blanc Fournier, C; Crouet, H; Desmonts, C; Dugué, AE; Grellard, JM; Guilloit, JM; Levy, C; Switsers, O | 1 |
Arnould, L; Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Coudert, B; Coutant, C; Desmoulins, I; Dygai-Cochet, I; Fumoleau, P; Guiu, S; Humbert, O; Riedinger, JM; Toubeau, M | 1 |
Cho, N; Chun, IK; Chung, JK; Im, SA; Jeong, JM; Jeong, S; Jung, KC; Kang, KW; Lee, DS; Lee, S; Lee, YS; Moon, WK; Yoon, HJ | 1 |
Benedetti Panici, P; Fischetti, M; Lio, S; Pecorella, I; Perniola, G; Tomao, F | 1 |
Han, K; Hong, IK; Sohn, YM | 1 |
Chae, BJ; Jung, NY; Kang, BJ; Kim, SH; Seo, YY; Yoo, IR | 1 |
Ahn, BC; Hong, CM; Jeong, SY; Kim, CY; Kim, DH; Lee, J; Lee, SW; Son, SH | 1 |
Cruz Mora, MÁ; Espinosa Aunión, R; García Vicente, AM; Gonzalez Ageitos, A; León Martín, AA; Muñoz Sánchez, Mdel M; Relea Calatayud, F; Soriano Castrejón, A; Van Gómez López, O | 1 |
Baron, M; Berghian, A; Dubray, B; Edet-Sanson, A; Forestier-Lebreton, F; Gardin, I; Georgescu, D; Gouel, P; Hapdey, S; Martin, B; Modzelewski, R; Picquenot, JM; Vera, P | 1 |
Errico, A | 1 |
Jo, JE; Kang, T; Kim, JY; Kim, S; Lee, SH | 1 |
Groheux, D | 1 |
Arnould, L; Bachelot, T; Berriolo-Riedinger, A; Bougnoux, P; Coeffic, D; Coudert, B; Coudert, M; Dupré, PF; Ferrero, JM; Gabelle, P; Giard, S; Hernandez, J; Kerbrat, P; Kerrou, K; Mouret-Reynier, MA; Paintaud, G; Petit, T; Pierga, JY; Prevost, JB; Thibault, G | 1 |
Chang, HT; Chiu, YL; Hu, C; Liu, RS; Peng, NJ | 1 |
Ahn, SG; Dong, SM; Han, K; Jeon, TJ; Jeong, J; Lee, HM; Lee, HW; Lee, SA; Park, JT; Ryu, YH; Son, EJ | 1 |
An, YS; Jung, YS; Kang, DK; Kim, TH; Lee, SJ; Yim, H; Yoon, JK | 1 |
Greenspan, D; Lebron, L; Pandit-Taskar, N | 1 |
Choi, BB; Jung, NY; Kim, SH; Sung, MS | 1 |
Han, W; Kang, KW; Koo, HR; Moon, WK; Park, IA; Park, JS | 1 |
Fujiwara, Y; Hamada, A; Hashimoto, J; Kanayama, Y; Kodaira, M; Kurihara, H; Miyakita, Y; Shimizu, C; Tamura, K; Tani, H; Watanabe, Y; Yamamoto, H; Yonemori, K; Yoshida, M; Yunokawa, M | 1 |
Chisin, R; Freedman, N; Klein, M; Orevi, M; Peretz, T; Tahover, E; Uziely, B | 1 |
Ahn, BC; Chae, YS; Jeong, SY; Lee, J; Lee, SW; Son, SH; Song, BI | 1 |
Kristian, A; Malinen, E; Pitman, KE; Rusten, E | 1 |
Dashevsky, B; Goldman, DA; Gönen, M; Hogan, MP; Hudis, C; Jochelson, M; Morrow, M; Osborne, JR; Riedl, CC; Ulaner, GA | 1 |
Alsharif, A; Cervino, AR; Chiacchio, S; DI Martino, F; Evangelista, L; Filidei, E; Ghilli, M; Manca, G; Naccarato, AG; Negri, A; Puccini, G; Roncella, M; Tredici, M; Volterrani, D | 1 |
Doihara, H; Ito, M; Iwamoto, T; Kaji, M; Miyoshi, S; Mizoo, T; Motoki, T; Nogami, T; Shien, T; Taira, N | 1 |
Bae, YK; Cho, IH; Chun, KA; Kong, E | 1 |
Freed, M; Kim, SG; Margolis, NE; McKellop, J; Melsaether, AN; Moy, L; Sigmund, EE | 1 |
Fujimoto, Y; Fukushima, K; Higuchi, T; Imamura, M; Kitajima, K; Miyagawa, Y; Miyoshi, Y; Murase, K; Nishimukai, A; Ozawa, H; Takatsuka, Y; Yanai, A | 1 |
Elkhuizen, PH; Koolen, BB; Rodenhuis, S; Rutgers, EJ; Stokkel, MP; Teixeira, SC; Valdés Olmos, RA; van der Noort, V; Vrancken Peeters, MT | 1 |
Inoue, T; Ishikawa, T; Kaneta, T; Narui, K; Noritake, M; Sakamaki, K; Sugae, S | 1 |
Chien, AJ; Esserman, LJ; Franc, BL; Hylton, NM; Joe, BN; Jones, EF; Li, W; Pampaloni, MH; Ray, KM; Seo, Y | 1 |
Catalano, M; Catalano, OA; Catana, C; Horn, GL; Iannace, C; Lehman, C; Lepore, M; Luongo, A; Mahmood, U; Rosen, BR; Salvatore, M; Signore, A; Soricelli, A; Vangel, M | 1 |
Iesato, A; Ito, KI; Ito, T; Kanai, T; Maeno, K; Mochizuki, Y; Oba, T; Ono, M; Takayama, F; Yoshizawa, A | 1 |
Deng, HF; Feng, YL; He, XH; Huang, KM; Liu, DJ; Liu, SS; Wen, GH; Yang, M; Yu, FZ; Yuan, JW | 1 |
Kasami, M; Uematsu, T; Yuen, S | 1 |
Higure, A; Hirata, K; Inoue, Y; Katsuki, T; Konishi, T; Nagata, J; Nagata, N; Nagata, T; Nakayama, Y; Okamoto, K; Shibao, K; Tsurudome, Y; Yamaguchi, K | 1 |
El-Kholy, MR; El-Shorbagy, E; Murakami, K; Zytoon, AA | 1 |
Abe, Y; Asakawa, H; Fukatsu, K; Ishida, J; Kobayashi, T; Kondoh, N; Mochizuki, H; Tamura, K; Tsuda, H; Ueda, S; Yamamoto, J; Yamamoto, M; Yamamoto, S | 1 |
Beorlegui, C; García-Velloso, MJ; Gil-Rendo, A; Martínez-Regueira, F; Rodriguez-Spiteri, N; Zornoza, G | 1 |
Boin, C; Bousquet, G; Cuvier, C; Espié, M; Giacchetti, S; Groheux, D; Hindié, E; Misset, JL; Moretti, JL; Teyton, P | 1 |
Alavi, A; Basu, S; Bergey, MR; Schnall, M; Sonnad, SS; Tchou, J; Tomaszewski, J | 1 |
Hoshi, K; Tozaki, M | 1 |
Fox, J; Ganju, V; Hart, S; Hofman, M; Midolo, P; Schneider-Kolsky, ME; Stuckey, J | 1 |
Aukema, TS; Gilhuijs, KG; Olmos, RA; Peeters, MJ; Russell, NS; Rutgers, EJ; Straver, ME; Vogel, WV | 1 |
Bouteille, C; Cimarelli, S; Heudel, P; Mognetti, T; Montella, A | 1 |
Bluemke, DA; Gabrielson, E; Jacobs, MA; Jeter, S; Ouwerkerk, R; Stearns, V; Wahl, R; Warzecha, H; Wolff, AC | 1 |
Kim, BS; Sung, SH | 1 |
Panfilenko, AA | 1 |
Bang, YJ; Cho, N; Chung, JK; Han, SW; Han, W; Im, SA; Kang, KW; Keam, B; Kim, JH; Kim, TY; Koh, Y; Moon, WK; Noh, DY; Oh, DY; Park, IA | 1 |
Andersson, M; Bernsdorf, M; Berthelsen, AK; Binderup, T; Graff, J; Kjær, A; Kroman, N; Loft, A; Tange, UB; Teilum, D; Wielenga, VT | 1 |
Choi, BB; Jeong, SH; Kang, BJ; Kim, SH; Lee, JH; Song, BJ; Yim, HW | 1 |
Ahn, BC; Chae, YS; Jeong, SY; Lee, J; Lee, SW; Lee, WK; Song, BI | 1 |
Ahn, JH; Ahn, SH; Gong, G; Jin, S; Jung, KH; Kim, HO; Kim, SB; Lee, JW; Moon, DH; Son, BH | 1 |
de Bazelaire, C; de Roquancourt, A; Delord, M; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hindié, E; Merlet, P; Toubert, ME; Vercellino, L | 1 |
Bachmann, S; Berger, J; Bleckmann, C; Bohuslavizki, KH; Dose, J; Habermann, CR; Jãnicke, F; Jenicke, L | 1 |
Buck, A; Dankerl, A; Glatting, G; Kalker, T; Kotzerke, J; Kühn, T; Mattfeldt, T; Reske, S; Schirrmeister, H; Shen, C | 1 |
Joyce, JM; Myers, DT; Petursson, SR; Pohland, ML | 1 |
Goering, UJ; Krahe, T; Kugel, H; Pietrzyk, U; Scharl, A; Scheidhauer, K; Theissen, P; Walter, C | 1 |
Bakheet, R; Bakheet, SM; Baslaim, MM; El-Foudeh, M; Ezzat, A; Tulbah, A | 1 |
Ahearn, TS; Chaturvedi, S; Gilbert, FJ; Heys, SD; Hutcheon, AW; Redpath, TW; Semple, SI; Smyth, EH; Staff, RT; Welch, AE | 1 |
Harling, H; Laoutliev, B; Neergaard, K; Simonsen, L | 1 |
Aigner, RM; Krippl, P; Langsenlehner, U; Renner, W; Samonigg, H; Schaffler, G; Wolf, G; Yazdani-Biuki, B | 1 |
Baker, JA; Coleman, RE; Rosen, EL; Soo, MS; Turkington, TG | 1 |
Fujii, T; Mochizuki, T; Morishige, I; Shigesawa, T; Shinohara, I; Sugawara, Y | 1 |
Hoksch, B; Jüngling, F; Körner, M; Schmid, RA; Weber, T | 1 |
Fischman, AJ; Kuter, I; Scott, JA; Wade, AA | 1 |
Ampil, F; Burton, G; Chu, QD; Johnson, LW; Li, BD; Lilien, D; Turnage, RH; Wolfort, RM | 1 |
Bénard, F; Langlois, MF; Leboeuf, R | 1 |
Luthra, K; Medhi, S; Purandare, N; Rangarajan, V; Samuel, AM; Shah, S | 1 |
Ahearn, TS; Gilbert, FJ; Heys, SD; Hutcheon, A; Redpath, TW; Semple, SI; Staff, RT; Welch, AE | 1 |
Drumm, D; Korn, RL; Kovalsky, ER; Layton, TA; May, CC; Orth, KM; Yost, AM | 1 |
Chung, A; Fujimoto, K; Hagiike, M; Karlan, S; Liou, D; Phillips, EH; Waxman, A | 1 |
Fukuda, H; Iwasaki, T; Katsura, H; Kawahara, K; Nakagawa, K; Nakane, S | 1 |
Abbey, CK; Borowsky, AD; Cardiff, RD; Cherry, SR; Gregg, JP | 1 |
Doot, RK; Dunnwald, LK; Kinahan, PE; Kurland, BF; Mankoff, DA; Muzi, M; Peterson, LM; Schubert, EK | 1 |
Li, JG; Li, YM; Zhao, TT | 1 |
Hayashi, M; Murakami, K; Oyama, T; Shimoda, W; Sunagawa, M | 1 |
Chen, JH; Li, D; Ling, R; Wang, J; Wang, L; Yao, Q | 1 |
Akin, ML; Filiz, AI; Kurt, Y; Sücüllü, I; Urhan, M | 1 |
Bonomo, G; Chiappa, A; Della Vigna, P; Ferrari, M; Mallia, A; Monfardini, L; Orsi, F; Paganelli, G; Ravasi, L; Travaini, LL; Trifirò, G | 1 |
Cristofanilli, M; Dawood, S; Gamez, C; Macapinlac, HA; Tateishi, U; Yeung, HW | 1 |
Abe, Y; Asakawa, H; Fukatsu, K; Hama, Y; Ishida, J; Kondo, N; Mochizuki, H; Shigekawa, T; Tamura, K; Tsuda, H; Ueda, S; Yamamoto, M | 1 |
Hortobagyi, GN; Kim, EE; Nieweg, OE; Singletary, SE; Wong, WH | 1 |
Göhring, UJ; Pietrzyk, U; Scharl, A; Scheidhauer, K; Schicha, H; Schomäcker, K; Wagner, R | 1 |
Bassa, P; Buzdar, AU; Hicks, KW; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
Göhring, UJ; Pietrzyk, U; Scharl, A; Scheidhauer, K; Schomäcker, K | 1 |
Hoekstra, HJ; Kole, AC; Nieweg, OE; Paans, AM; Plukker, JT; Pruim, J; Schraffordt Koops, H; Vaalburg, W | 1 |
Agresti, R; Bogni, A; Bombardieri, E; Chiesa, C; Crippa, F; De Sanctis, V; Delledonne, V; Greco, M; Leutner, M; Pascali, C; Salvadori, B; Seregni, E | 1 |
Bakheet, SM; Bakri, Y; Ezzat, A; Powe, J | 1 |
Kusuoka, H; Nishimura, T; Shiba, E; Tatsumi, M; Yutani, K | 1 |
Fujii, H; Ide, M; Kubota, M; Shohtsu, A; Tajima, T; Takahashi, W; Umemura, S; Yasuda, S | 1 |
Nishimura, T; Tatsumi, M; Uehara, T; Yutani, K | 1 |
Avril, N; Dose, J; Graeff, H; Jänicke, F; Kuhn, W; Nährig, J; Römer, W; Sattler, D; Schelling, M; Schwaiger, M; Werner, M | 1 |
Avril, N; Bense, S; Dose, J; Graeff, H; Kuhn, W; Rosé, CA; Schelling, M; Schwaiger, M; Weber, W; Ziegler, S | 1 |
Avril, N; Dose, J; Jänicke, F; Menzel, M; Nathrath, W; Schelling, M; Schwaiger, M; Weber, W | 1 |
Brown, RS; Goodman, TM; Greenson, JK; Wahl, RL; Zasadny, KR | 1 |
5 review(s) available for fluorodeoxyglucose f18 and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Topics: Adult; Bone Marrow Neoplasms; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2013 |
PET Imaging of Breast Cancer: Role in Patient Management.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Molecular imaging using PET for breast cancer.
Topics: Bevacizumab; Breast Neoplasms; Carcinoma, Ductal, Breast; Cetuximab; Dideoxynucleosides; ErbB Receptors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Norprogesterones; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, Progesterone; Receptors, Vascular Endothelial Growth Factor; Trastuzumab | 2016 |
[PET/CT in breast cancer: an update].
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Dideoxynucleosides; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Treatment Outcome | 2009 |
Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography.
Topics: Animals; Carcinoma in Situ; Carcinoma, Ductal, Breast; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Longitudinal Studies; Lymphatic Metastasis; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Positron-Emission Tomography; Whole-Body Counting | 2006 |
9 trial(s) available for fluorodeoxyglucose f18 and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER):
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Survival Rate; Taxoids; Trastuzumab | 2014 |
Is (18)F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Taxoids; Treatment Outcome | 2010 |
Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiography; Radiopharmaceuticals; Sodium Isotopes; Taxoids; Treatment Outcome | 2011 |
FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Topics: Adenocarcinoma; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone; Reproducibility of Results; Statistics as Topic; Tissue Distribution; Tomography, Emission-Computed | 2002 |
Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Delivery Systems; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Treatment Outcome; Tumor Burden | 2006 |
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
Topics: Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Expression of hexokinase II and Glut-1 in untreated human breast cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Excitatory Amino Acid Transporter 2; Fluorodeoxyglucose F18; Hexokinase; Humans; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method | 2002 |
119 other study(ies) available for fluorodeoxyglucose f18 and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Prognostic value of metabolic activity of the psoas muscle evaluated by preoperative
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Insulin Resistance; Liver; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Psoas Muscles; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Triple Negative Breast Neoplasms | 2021 |
Assessing the correlation between FDG PET findings of IDC breast carcinoma and histopathology of coexisting ductal carcinoma in-situ.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Prognostic impact of
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Prediction of Clinical Molecular Typing of Breast Invasive Ductal Carcinoma Using
Topics: Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Triple Negative Breast Neoplasms | 2023 |
Gastric and Bone Metastases Arising from Invasive Lobular Carcinoma With Ductal Carcinoma Occurring in one Breast Synchronously.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Stomach | 2023 |
FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer.
Topics: B7-H1 Antigen; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphocytes, Tumor-Infiltrating; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2020 |
Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning.
Topics: Adult; Aged; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammatory Breast Neoplasms; Middle Aged; Neoplasm Staging; Patient Care Planning; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Topics: Adult; Animals; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Onchocerca volvulus; Onchocerciasis; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2020 |
Utility of
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate | 2020 |
A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Machine Learning; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Prognostic Value of Percentage Change in Metabolic Parameters as Measured by Dual-Time Point
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Premenopause; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2017 |
Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2017 |
Relationship between reticuloendothelial systems' FDG uptake level and clinicopathological features in patient with invasive ductal breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mononuclear Phagocyte System; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Reliability of
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Whole Body Imaging | 2017 |
Percentage change of primary tumor on 18F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Regression Analysis; Retrospective Studies | 2017 |
Clinicopathological Features of Ductal Carcinoma
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Assessment of biological and clinical aggressiveness of invasive ductal breast cancer using baseline 18F-FDG PET/CT-derived volumetric parameters.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2018 |
Volume-based metabolic parameter of breast cancer on preoperative 18F-FDG PET/CT could predict axillary lymph node metastasis.
Topics: Adult; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2017 |
Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.
Topics: Adult; Axilla; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2018 |
Relationship Between FDG Uptake and Neutrophil/Lymphocyte Ratio in Patients with Invasive Ductal Breast Cancer.
Topics: C-Reactive Protein; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Lymphocyte Count; Lymphocytes; Middle Aged; Neoplasm Grading; Neutrophils; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
Correlation of tumor uptake on breast-specific gamma imaging and fluorodeoxyglucose PET/CT with molecular subtypes of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2018 |
Paraneoplastic syndrome - a rare but treatable cause of non-thyroid-related extraocular muscle enlargement.
Topics: Aged; Antigens, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Diplopia; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hypertrophy; Letrozole; Magnetic Resonance Imaging; Ocular Motility Disorders; Oculomotor Muscles; Paraneoplastic Syndromes; Piperazines; Positron-Emission Tomography; Prednisone; Pyridines | 2019 |
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paraneoplastic Syndromes; Positron Emission Tomography Computed Tomography; Sarcoidosis; Whole Body Imaging | 2019 |
Thyroid metastasis from breast cancer detected by 18F-FDG PET/CT.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2019 |
Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Medical Overuse; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen | 2019 |
Prognostic Significance of Metabolic Parameters and Textural Features on
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis | 2019 |
Metabolic and volume-based parameters of (18F)FDG PET/CT for primary mass and axillary lymph node metastasis in patients with invasive ductal carcinoma: a retrospective analysis in relation to molecular subtype, axillary lymph node metastasis and immunohi
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2019 |
Diffuse FDG uptake due to fat necrosis following transverse rectus abdominus myocutaneous (TRAM) flap reconstruction.
Topics: Biological Transport; Breast Neoplasms; Carcinoma, Ductal, Breast; Fat Necrosis; Female; Fluorodeoxyglucose F18; Humans; Mammaplasty; Middle Aged; Postoperative Complications; Radiography; Radionuclide Imaging; Rectus Abdominis | 2013 |
Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
A new method for apparent diffusion coefficient measurement using sequential (18)F-FDG PET and MRI: correlation with histological grade of invasive ductal carcinoma of the breast.
Topics: Adult; Biological Transport; Breast Neoplasms; Carcinoma, Ductal, Breast; Diffusion; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Observer Variation; Positron-Emission Tomography; Time Factors; Young Adult | 2013 |
Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Ductal, Breast; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Triple Negative Breast Neoplasms | 2013 |
Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biomarkers, Tumor; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2013 |
Detection of internal mammary lymph node metastasis with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with stage III breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphoscintigraphy; Middle Aged; Neoplasm Staging; Organotechnetium Compounds; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Young Adult | 2014 |
Staging the axilla in breast cancer patients with ¹⁸F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?
Topics: Algorithms; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Limit of Detection; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
HER2-positive breast cancer: ¹⁸F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy.
Topics: Adult; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Bridged-Ring Compounds; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Genes, erbB-2; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Taxoids; Tomography, X-Ray Computed; Trastuzumab; Treatment Outcome | 2014 |
Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.
Topics: Adult; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Coordination Complexes; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Oligopeptides; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2014 |
Benign schwannoma in supraclavicular region: a false-positive lymph node recurrence of breast cancer suspected by PET scan.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neurilemmoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Role of [18F]fluorodeoxyglucose positron emission tomography-computed tomography, sonography, and sonographically guided fine-needle aspiration biopsy in the diagnosis of axillary lymph nodes in patients with breast cancer: comparison of diagnostic perfor
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Endoscopic Ultrasound-Guided Fine Needle Aspiration; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2014 |
Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary; Young Adult | 2016 |
Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |
Glycolytic activity with 18F-FDG PET/CT predicts final neoadjuvant chemotherapy response in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2014 |
Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Breast cancer. Predicting nonresponders--light at the end of the PET tunnel.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Receptor, ErbB-2 | 2015 |
Preoperative 18F-FDG PET/CT predicts disease-free survival in patients with primary invasive ductal breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Predicting pathological complete response in breast cancer early.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Receptor, ErbB-2 | 2014 |
Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cohort Studies; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2014 |
Correlation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2015 |
Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; ErbB Receptors; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Correlation between (18)F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer.
Topics: Adult; Aged; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms; Tumor Burden | 2015 |
Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Variability of dynamic 18F-FDG-PET data in breast cancer xenografts.
Topics: Animals; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Heterografts; Mammary Neoplasms, Experimental; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms | 2015 |
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone and Bones; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies | 2015 |
Association between semiquantitative PET parameters and molecular subtypes of breast invasive ductal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
Correlation between 18F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography and Clinicopathological Features in Invasive Ductal Carcinoma of the Breast.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen | 2015 |
Integrated PET/MR mammography for quantitative analysis and correlation to prognostic factors of invasive ductal carcinoma.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis | 2018 |
Assessment of Aggressiveness of Breast Cancer Using Simultaneous 18F-FDG-PET and DCE-MRI: Preliminary Observation.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Prognostic significance of preoperative
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gonadotropin-Releasing Hormone; Humans; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tamoxifen; Tumor Burden | 2016 |
PET/CT with
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Trastuzumab; Young Adult | 2017 |
Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Taxoids; Trastuzumab; Treatment Outcome; Whole Body Imaging | 2017 |
Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; BRCA1 Protein; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mastectomy; Neoadjuvant Therapy; Neoplasm Grading; Positron-Emission Tomography; Treatment Outcome | 2017 |
PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Middle Aged; Multimodal Imaging; Neoplasm Staging; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Young Adult | 2017 |
A Case of Adenomyoepithelioma of the Breast Showing Strong Uptake of
Topics: Adenomyoepithelioma; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Mastectomy, Segmental; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Ultrasonography, Mammary | 2017 |
[Standard uptake value of 18F-fluorine-2-deoxyglucose is correlated with the expression of estrogen receptor in duct carcinoma of breast].
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Reference Values | 2008 |
Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
[A case of low grade ductal carcinoma in situ of the breast with difficulties in making the preoperative diagnosis after detection by FDG-PET].
Topics: Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography | 2008 |
Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Ductal, Breast; Cell Cycle Proteins; Chromosomal Proteins, Non-Histone; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Microfilament Proteins; Middle Aged; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiography; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric | 2008 |
Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Statistics, Nonparametric; Young Adult | 2009 |
Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancer.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Proliferation; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Mitotic Index; Pilot Projects; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies | 2010 |
1H MR spectroscopy of invasive ductal carcinoma: correlations with FDG PET and histologic prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Japan; Magnetic Resonance Spectroscopy; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Protons; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2010 |
Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
Topics: Adult; Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2010 |
Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2012 |
[Role of positron-emission tomography with 18F-FDG in the diagnosis of breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sentinel Lymph Node Biopsy; Taxoids; Tomography, X-Ray Computed | 2013 |
Preoperative PET/CT in early-stage breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2012 |
18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
18 F-fluorodeoxyglucose uptake predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: a retrospective cohort study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Mastectomy; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.
Topics: Adult; Aged; Analysis of Variance; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Contrast Media; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2012 |
Comparison of fluorodeoxyglucose positron emission tomography and "conventional diagnostic procedures" for the detection of distant metastases in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2002 |
Incidental detection of primary breast carcinoma with a modified coincident camera in a patient with non-Hodgkin's lymphoma and melanoma.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Melanoma; Neoplasm Staging; Neoplasms, Multiple Primary; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Whole-Body Counting | 2002 |
Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions.
Topics: Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Middle Aged; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastitis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed | 2003 |
The relationship between vascular and metabolic characteristics of primary breast tumours.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Rectal metastasis from infiltrating lobular breast carcinoma: imaging with 18F-FDG PET.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Rectal Neoplasms; Tomography, Emission-Computed | 2005 |
The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Polymorphism, Genetic; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2004 |
Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Breast Diseases; Breast Neoplasms; Calcinosis; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2005 |
Bone metastasis detected by FDG PET in a patient with breast cancer and fibrous dysplasia.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Carcinoma, Ductal, Breast; Female; Fibrocystic Breast Disease; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Mucin-1; Radionuclide Imaging; Radiopharmaceuticals; Whole-Body Counting | 2005 |
Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer. CASE 3. Hoarseness caused by cancer metastasis to the vagus nerve.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Cranial Nerve Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hoarseness; Humans; Melanoma; Tomography, X-Ray Computed; Vagus Nerve Diseases | 2005 |
Flare response in 18F-fluoride ion PET bone scanning.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Thoracic Vertebrae | 2006 |
The role of whole-body fluorine-18-FDG positron emission tomography in the detection of recurrence in symptomatic patients with stages II and III breast cancer.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Mastectomy, Segmental; Mediastinal Neoplasms; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2006 |
F-18 FDG PET-CT appearance of metastatic brachial plexopathy in a case of carcinoma of the breast.
Topics: Brachial Plexus; Brachial Plexus Neuropathies; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cicatrix; Combined Modality Therapy; Diagnosis, Differential; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Mastectomy; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy, Adjuvant; Tomography, X-Ray Computed | 2006 |
Unexpected focal hypermetabolic activity in the breast: significance in patients undergoing 18F-FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Child; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Preoperative FDG-PET for axillary metastases in patients with breast cancer.
Topics: Axilla; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2006 |
Pulmonary suture abscess with false-positive 18F-fluorodeoxyglucose positron emission scan mimicking lung cancer recurrence.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Abscess; Lung Neoplasms; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sutures | 2006 |
Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Filgrastim; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins | 2007 |
[Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
The relationship between FDG uptake in PET scans and biological behavior in breast cancer.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone | 2007 |
[Value of fused 18F-FDG PET/CT images in predicting efficacy of neoadjuvant chemotherapy on breast cancer].
Topics: Adult; Aged; Apoptosis; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; In Situ Nick-End Labeling; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Pulmonary echinococcosis mimicking multiple lung metastasis of breast cancer: the role of fluoro-deoxy-glucose positron emission tomography.
Topics: Albendazole; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Diagnosis, Differential; Echinococcosis, Pulmonary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Treatment Outcome | 2008 |
Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results.
Topics: Ablation Techniques; Adenocarcinoma; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron-Emission Tomography; Radiofrequency Therapy; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2008 |
Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2008 |
Positron emission tomography of glucose metabolism in breast cancer. Potential for tumor detection, staging, and evaluation of chemotherapy.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Tomography, Emission-Computed; Xeromammography | 1993 |
Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Staging; Time Factors; Tomography, Emission-Computed; Ultrasonography, Mammary | 1996 |
Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm, Residual; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography, Mammary | 1996 |
[Detection of multi-focal breast carcinoma using 2[18F] fluoro-deoxy-D-glucose positron emission tomography (FDG-PET)].
Topics: Adult; Blood Glucose; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Deoxyglucose; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Fluorodeoxyglucose F18; Glycolysis; Humans; Neoplasm Staging; Neoplasms, Second Primary; Tomography, Emission-Computed | 1996 |
Standardized uptake value and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]tyrosine PET.
Topics: Blood Glucose; Breast; Breast Neoplasms; Carbon Radioisotopes; Carcinoma, Ductal, Breast; Deoxyglucose; Female; Fibrocystic Breast Disease; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed; Tyrosine | 1997 |
Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
Topics: Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Incidental second primary in the breast detected by F-18 FDG positron emission tomography scan.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms, Second Primary; Radiopharmaceuticals; Teratoma; Tomography, Emission-Computed | 1998 |
Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Middle Aged; Phantoms, Imaging; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
A small breast cancer detected by PET.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Effect of patients' being prone during FDG PET for the diagnosis of breast cancer.
Topics: Adult; Aged; Blood Glucose; Breast; Breast Neoplasms; Calcinosis; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Predictive Value of Tests; Prone Position; Supine Position; Tomography, Emission-Computed | 1999 |
Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Paclitaxel; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
Topics: Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Glucose; Humans; Immunohistochemistry; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |